Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business. Kunming Longjin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Kunming, China.
Research context
Kunming Longjin Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Kunming Longjin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.
From a valuation standpoint, the stock is 33.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.9.
Kunming Longjin Pharmaceutical Co., Ltd's total revenue rose by 11.9% to $64M since the same quarter in the previous year.
Its net income has increased by 735.4% to $4M since the same quarter in the previous year.
Finally, its free cash flow fell by 153.6% to $-5M since the same quarter in the previous year.
Based on the above factors, Kunming Longjin Pharmaceutical Co., Ltd gets an overall score of 2/5.